These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11563632

  • 1. Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.
    Simon M, Köster G, Ludwig M, Mahlberg R, Rho S, Watzka M, Schramm J.
    Acta Neuropathol; 2001 Aug; 102(2):167-74. PubMed ID: 11563632
    [Abstract] [Full Text] [Related]

  • 2. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M, Park TW, Köster G, Mahlberg R, Hackenbroch M, Boström J, Löning T, Schramm J.
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [Abstract] [Full Text] [Related]

  • 3. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 4. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H.
    Cancer; 2000 Jul 01; 89(1):60-8. PubMed ID: 10897001
    [Abstract] [Full Text] [Related]

  • 5. Cloning and characterization of p10, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor.
    Tsubari M, Tiihonen E, Laiho M.
    Cancer Res; 1997 Jul 15; 57(14):2966-73. PubMed ID: 9230210
    [Abstract] [Full Text] [Related]

  • 6. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I, Benet M, Jiménez M, Alzabin S, Malumbres M, Pellicer A.
    Cancer Res; 2005 Apr 15; 65(8):3249-56. PubMed ID: 15833857
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]

  • 8. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM, Sass K, Gäbel G, Bergert H, Thiery J, Teupser D.
    Atherosclerosis; 2011 Feb 01; 214(2):264-70. PubMed ID: 20637465
    [Abstract] [Full Text] [Related]

  • 9. Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.
    Solomon DA, Kim JS, Jean W, Waldman T.
    Cancer Res; 2008 Nov 01; 68(21):8657-60. PubMed ID: 18974105
    [Abstract] [Full Text] [Related]

  • 10. p15 promoter methylation - a novel prognostic marker in glioblastoma patients.
    Wemmert S, Bettscheider M, Alt S, Ketter R, Kammers K, Feiden W, Steudel WI, Rahnenführer J, Urbschat S.
    Int J Oncol; 2009 Jun 01; 34(6):1743-8. PubMed ID: 19424593
    [Abstract] [Full Text] [Related]

  • 11. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 01; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 12. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.
    Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin WS, Pour PM, Song H, Gold B, Batra SK, Weghorst CM.
    Gene; 2001 Oct 31; 278(1-2):235-43. PubMed ID: 11707341
    [Abstract] [Full Text] [Related]

  • 13. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 14. Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.
    Simon M, Köster G, Menon AG, Schramm J.
    Acta Neuropathol; 1999 Nov 04; 98(5):444-52. PubMed ID: 10541865
    [Abstract] [Full Text] [Related]

  • 15. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 04; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 04; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 19. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.
    J Neuropathol Exp Neurol; 2005 May 04; 64(5):398-403. PubMed ID: 15892297
    [Abstract] [Full Text] [Related]

  • 20. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 04; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.